Hidden Risks of Private Equity MSO Deals for California Physicians

Private equity investment in healthcare continues to expand aggressively across California. Physicians are routinely approached with promises of:

• Large future payouts

• Operational expertise

• Increased profitability

• Reduced administrative burdens

• Practice growth opportunities

• “Partnership” structures designed to maximize value

For many physicians, these transactions can appear highly attractive — particularly after years of dealing with declining reimbursements, staffing challenges, regulatory burdens, and rising operational costs. However, physicians considering Management Services Organization (“MSO”) arrangements with private equity groups should approach these transactions with extreme caution. In many cases, the economic reality of these deals looks very different from the initial marketing presentation.

The Typical Private Equity MSO Model

Because California prohibits the corporate practice of medicine (“CPOM”), private equity groups generally cannot directly own physician practices. Instead, investors commonly utilize a Management Services Organization structure. Under this model:

• The physician technically owns the professional medical corporation

• The MSO provides management and administrative services

• The private equity group controls the MSO

• The physician signs long-term management agreements

• The physician often continues practicing for years after the transaction closes

The physician may receive an upfront payment, but a substantial portion of the promised compensation is frequently tied to future performance, profitability targets, earn-outs, rollover equity, or deferred compensation structures. This is where physicians must be especially careful.

The Physician Often Carries the Long-Term Risk

One of the most important realities physicians must understand is that private equity firms are financial investors - not healthcare providers. Their objective is investment return. The physician, however, remains:

• The licensed healthcare provider

• The party subject to Medical Board oversight

• The professional legally responsible for patient care

• The individual whose license remains exposed

Even when the MSO heavily influences operations, physicians often continue bearing substantial professional and legal risk long after the transaction closes.

The “Future Payment” Problem

Many MSO transactions are marketed based on projected future payouts. Physicians may be told:

• “You will receive additional distributions later.”

• “The rollover equity will significantly increase in value.”

• “The second liquidity event will generate substantial wealth.”

• “The earn-out structure rewards future growth.”

But these future payments often depend entirely on whether the MSO or consolidated entity ultimately becomes profitable enough to distribute funds. If the business

performs poorly, private equity groups may:

• Restructure the MSO

• Refinance the entity

• Terminate management personnel

• Sell assets

• Shut down operations

• Place the MSO into bankruptcy

A concerning undercurrent is the incentive of the other “physician participants”.  Many of the other physician participants in the MSO will elect to work less or at a more leisurely pace since their production is factored into the whole of the practices in under the MSO – why work harder than the rest when the payout in the end is a factor of all the practices revenue.  This attitude dilutes incentive to perform better than the other practices.  In fact, it creates the opposite incentive – work less and allow the others in the physician pool within the MSO to carry the underperforming practices.  This attitude can be contagious with the results being catastrophic for the MSO.

Meanwhile, the physician may have already:

• Given up ownership control

• Signed restrictive agreements

• Continued practicing under operational pressure

• Remained exposed to regulatory risk

• Relied on compensation promises that never materialize

• 
  

In some cases, physicians spend years working toward financial incentives that ultimately never get paid.

Bankruptcy Risk and Physician Exposure

A significant concern in these structures is that the MSO itself is often designed as a separate entity specifically intended to isolate financial risk. If the business fails:

• Investors may lose only invested capital

• The MSO may file bankruptcy

• Deferred physician compensation may disappear

• Earn-out obligations may become worthless

Yet the physician’s exposure does not disappear nearly as easily.

The physician still may face:

• Medical Board scrutiny

• Billing investigations

• Employment disputes

• Patient care liability

• Restrictive covenant disputes

• Ongoing reputational damage

Even if the physician’s medical license survives the bankruptcy, The promised payout may not.

The Illusion of “Operational Expertise”

Private equity groups often market themselves as bringing sophisticated operational improvements that physicians supposedly cannot implement independently.  In reality, many MSO “value creation” strategies involve relatively straightforward revenue enhancement techniques such as:

• Increased coding optimization

• Expanded ancillary services

• More aggressive scheduling

• Productivity tracking

• Centralized billing

• Cost-cutting measures

• Staffing reductions

• Marketing optimization

• Revenue cycle management

Many of these operational improvements are not unique or proprietary. In fact, physicians can often implement similar efficiency improvements independently while:

• Maintaining ownership control

• Preserving clinical autonomy

• Avoiding long-term contractual restrictions

• Retaining future enterprise value

Physicians should carefully evaluate whether the proposed transaction truly creates unique value  or merely monetizes operational changes the practice could achieve on its own.

The Pressure to Increase Revenue

Another concern is that private equity-backed MSOs are frequently under substantial pressure to generate rapid returns for investors. This pressure can create incentives to:

• Increase patient volume

• Shorten appointment times

• Expand high-margin services

• Aggressively maximize billing

• Reduce operational expenses affecting patient care

While these practices may improve financial metrics, they can also create tension with the physician’s professional and ethical obligations. Importantly, regulators generally focus on the physician’s conduct — not the investor’s return objectives.

Corporate Practice of Medicine Concerns

California’s Corporate Practice of Medicine doctrine remains a major legal issue in these arrangements. Even when documents state that physicians retain “clinical control,” the operational reality may look very different. Potential warning signs include:

• Investor control over staffing

• Productivity quotas

• Budget restrictions affecting patient care

• Mandatory vendor relationships

• Pressure regarding treatment protocols

• Restrictions on physician autonomy

• Financial incentives tied to clinical decisions

When non-physicians effectively control medical decision-making, the arrangement may violate California law.

Questions Physicians Should Ask Before Signing

Before entering any MSO transaction, physicians should carefully evaluate:

• Who truly controls operations?

• What compensation is guaranteed versus contingent?

• What happens if profitability targets are not achieved?

• What protections exist if the MSO fails?

• How long is the physician obligated to remain?

• What are the restrictive covenant provisions?

• Who controls staffing and budgeting?

• What happens during disputes or termination?

• What professional liability remains with the physician?

Many physicians focus heavily on the upfront payment while underestimating the long-term contractual and regulatory consequences.

Sophisticated Legal Review Is Essential

These agreements are often drafted by highly sophisticated transactional counsel representing institutional investors. The documents may contain:

• Complex compensation waterfalls

• Broad management rights

• Restrictive termination provisions

• Long-term non-compete structures where permitted

• Equity rollover requirements

• Significant physician obligations

Physicians should obtain independent healthcare counsel familiar with:

• California healthcare law

• Corporate practice restrictions

• Fee splitting rules

• MSO structures

• Medical Board enforcement trends

• Healthcare transaction risk allocation

Final Thoughts

Private equity MSO transactions are not inherently improper. Some can create legitimate operational efficiencies and growth opportunities. However, physicians should approach these deals with a clear understanding of the underlying incentives and risks. In many cases:

• The physician continues bearing the professional liability

• The investor controls the financial structure

• Future compensation remains uncertain

• Operational “improvements” may be achievable independently

• The physician’s long-term autonomy may be significantly reduced

Most importantly, physicians must remember that their medical license and the responsibilities that come with it cannot be transferred to a private equity firm.

Before signing any MSO agreement, physicians should carefully evaluate whether the promised benefits truly outweigh the long-term legal, financial, and professional risks.

AI Disclosure:  This post was written with the assistance of an AI language model. The human author provided the topic and key points, verified the information, and performed all final editing. The AI (ChatGPT) helped expand on the details and refine the writing. The final content was reviewed and edited by a human to ensure accuracy and quality.